Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)
Clinical trial NCT01992536 · COMPLETED
Trial details
- NCT number
- NCT01992536
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-05-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.